Depression moderates the associations between beliefs about medicines and medication adherence in patients with rheumatoid arthritis: Cross-sectional study
Restricted accessResearch articleFirst published online August, 2018
Depression moderates the associations between beliefs about medicines and medication adherence in patients with rheumatoid arthritis: Cross-sectional study
The ‘necessity–concerns framework’ postulates that patients’ adherence behaviour is influenced by beliefs about the necessity and the concerns patients have regarding their prescribed medicines. We hypothesized that depression moderates the associations between beliefs about medicines and medication adherence among people with rheumatoid arthritis. Using multivariate logistic regression, we observed that people experiencing more depressive symptoms showed stronger associations between necessity beliefs and adherence as well as attenuated associations between concerns and adherence, respectively, in a cross-sectional sample (N = 361). Thus, depression moderates the associations postulated in the ‘necessity–concerns framework’ in a differential way in people with rheumatoid arthritis.
Cabrera-MarroquinRContreras-YanezIAlcocer-CastillejosN. (2014) Major depressive episodes are associated with poor concordance with therapy in rheumatoid arthritis patients: The impact on disease outcomes. Clinical and Experimental Rheumatology32(6): 904–913.
2.
CoscoTDDoyleFWardM. (2012) Latent structure of the hospital anxiety and depression scale: A 10-year systematic review. Journal of Psychosomatic Research72(3): 180–184.
3.
CovicTCummingSRPallantJF. (2012) Depression and anxiety in patients with rheumatoid arthritis: Prevalence rates based on a comparison of the Depression, Anxiety and Stress Scale (Dass) and the hospital, Anxiety and Depression Scale (Hads). BMC Psychiatry12: 6.
4.
De ThurahANorgaardMHarderI. (2010) Compliance with methotrexate treatment in patients with rheumatoid arthritis: Influence of patients’ beliefs about the medicine: A prospective cohort study. Rheumatology International30(11): 1441–1448.
5.
DimatteoMRLepperHSCroghanTW (2000) Depression is a risk factor for noncompliance with medical treatment: Meta-analysis of the effects of anxiety and depression on patient adherence. Archives of Internal Medicine160(14): 2101–2107.
6.
DougadosMSoubrierMAntunezA. (2014) Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: Results of an international, cross-sectional study (Comora). Annals of the Rheumatic Diseases73(1): 62–68.
7.
FuchsJRabenbergMScheidt-NaveC (2013) [Prevalence of selected musculoskeletal conditions in Germany: Results of the German health interview and examination survey for adults (Degs1)]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz56(5–6): 678–686.
8.
HayesAF (2012) Process: A versatile computational tool for observed variable mediation, moderation, and conditional process modeling [White Paper]. Available at: http://www.afhayes.com/public/process2012.pdf
9.
HorneRWeinmanJ (1999) Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. Journal of Psychosomatic Research47(6): 555–567.
10.
HorneRChapmanSCParhamR. (2013) Understanding patients’ adherence-related beliefs about medicines prescribed for long-term conditions: A meta-analytic review of the necessity-concerns framework. PLoS ONE8(12): e80633.
11.
HorneRWeinmanJHankinsM (1999) The beliefs about medicines questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medication. Psychology & Health14(1): 1–24.
12.
MahlerCHermannKHorneR. (2010) Assessing reported adherence to pharmacological treatment recommendations: Translation and evaluation of the Medication Adherence Report Scale (Mars) in Germany. Journal of Evaluation in Clinical Practice16(3): 574–579.
13.
MahlerCHermannKHorneR. (2012) Patients’ beliefs about medicines in a primary care setting in Germany. Journal of Evaluation in Clinical Practice18(2): 409–413.
14.
MatchamFRaynerLSteerS. (2013) The prevalence of depression in rheumatoid arthritis: A systematic review and meta-analysis. Rheumatology52(12): 2136–2148.
15.
MatchamFScottICRaynerL. (2014) The impact of rheumatoid arthritis on quality-of-life assessed using the Sf-36: A systematic review and meta-analysis. Seminars in Arthritis and Rheumatism44(2): 123–130.
16.
MeiranNDiamondGMToderD. (2011) Cognitive rigidity in unipolar depression and obsessive compulsive disorder: Examination of task switching, stroop, working memory updating and post-conflict adaptation. Psychiatry Research185(1–2): 149–156.
17.
MorrisAYelinEHPanopalisP. (2011) Long-term patterns of depression and associations with health and function in a panel study of rheumatoid arthritis. Journal of Health Psychology16(4): 667–677.
18.
NeameRHammondA (2005) Beliefs about medications: A questionnaire survey of people with rheumatoid arthritis. Rheumatology44(6): 762–767.
19.
NestoriucYOravEJLiangMH. (2010) Prediction of nonspecific side effects in rheumatoid arthritis patients by beliefs about medicines. Arthritis Care & Research62(6): 791–799.
20.
RathbunAMReedGWHarroldLR (2013) The temporal relationship between depression and rheumatoid arthritis disease activity, treatment persistence and response: A systematic review. Rheumatology52(10): 1785–1794.
21.
RichetinJConnerMPeruginiM (2011) Not doing is not the opposite of doing: Implications for attitudinal models of behavioral prediction. Personality and Social Psychology Bulletin31(1): 40–54.
SpruillTMOgedegbeGHarroldLR. (2014) Association of medication beliefs and self-efficacy with adherence in urban his panic and African-American rheumatoid arthritis patients. Annals of the Rheumatic Diseases73(1): 317–318.
24.
TreharneGJLyonsACKitasGD (2004) Medication adherence in rheumatoid arthritis: Effects of psychosocial factors. Psychology, Health and Medicine9(3): 337–349.
25.
van den BemtBJvandenHoogenFHBenraadB. (2009) Adherence rates and associations with nonadherence in patients with rheumatoid arthritis using disease modifying antirheumatic drugs. Journal of Rheumatology36(10): 2164–2170.
26.
van den BemtBJZwikkerHEvan den EndeCH (2012) Medication adherence in patients with rheumatoid arthritis: A critical appraisal of the existing literature. Expert Review of Clinical Immunology8(4): 337–351.
27.
VangeliEBakhshiSBakerA. (2015) A systematic review of factors associated with non-adherence to treatment for immune-mediated inflammatory diseases. Advances in Therapy32(11): 983–1028.
28.
WeightmanMJAirTMBauneBT (2014) A review of the role of social cognition in major depressive disorder. Frontiers in Psychiatry5: 179.
29.
WellsGBeckerJCTengJ. (2009) Validation of the 28-joint disease activity score (Das28) and European league against rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the Das28 based on erythrocyte sedimentation rate. Annals of the Rheumatic Diseases68(6): 954–960.
30.
WiscoBENolen-HoeksemaS (2010) Interpretation bias and depressive symptoms: The role of self-relevance. Behaviour Research and Therapy48(11): 1113–1122.
31.
ZigmondASSnaithRP (1983) The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica67(6): 361–370.
32.
ZwikkerHvan den BemtBvan den EndeC. (2012) Development and content of a group-based intervention to improve medication adherence in non-adherent patients with rheumatoid arthritis. Patient Education and Counseling89(1): 143–151.
33.
ZwikkerHEVan DulmenSDen BroederAA. (2014) Perceived need to take medication is associated with medication non-adherence in patients with rheumatoid arthritis. Patient Preference and Adherence8: 1635–1645.
